Related references
Note: Only part of the references are listed.Impact of body mass index on cardiac adrenergic derangement in heart failure patients: a 123I-mIBG imaging study
Klara Komici et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Coronary Sinus Neuropeptide Y Levels and Adverse Outcomes in Patients With Stable Chronic Heart Failure
Olujimi A. Ajijola et al.
JAMA CARDIOLOGY (2020)
Impact of Galectin-3 Circulating Levels on Frailty in Elderly Patients with Systolic Heart Failure
Klara Komici et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Prognostic value of pupil area for all-cause mortality in patients with heart failure
Kohei Nozaki et al.
ESC HEART FAILURE (2020)
Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers
Josip Andelo Borovac et al.
WORLD JOURNAL OF CARDIOLOGY (2020)
G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases
Cristina Murga et al.
FRONTIERS IN PHARMACOLOGY (2019)
β-Adrenergic Receptor Signaling and Heart Failure: From Bench to Bedside
Leonardo Bencivenga et al.
HEART FAILURE CLINICS (2019)
Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study
Josip A. Borovac et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Aldosterone Jeopardizes Myocardial Insulin and β-Adrenergic Receptor Signaling via G Protein-Coupled Receptor Kinase 2
Alessandro Cannavo et al.
FRONTIERS IN PHARMACOLOGY (2019)
Alteration of myocardial GRK2 produces a global metabolic phenotype
Benjamin P. Woodall et al.
JCI INSIGHT (2019)
GRK2 as a therapeutic target for heart failure
Alessandro Cannavo et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
ST2 as a novel prognostic marker in end-stage renal disease patients on hemodiafiltration
Evgenija Homsak et al.
CLINICA CHIMICA ACTA (2018)
Novel heart failure biomarkers: why do we fail to exploit their potential?
Arnold Piek et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2018)
Left atrial rather than left ventricular impaired mechanics are associated with the pro-fibrotic ST2 marker and outcomes in heart failure with preserved ejection fraction
A. I. Nagy et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Established and Emerging Roles of Biomarkers in Heart Failure
Nasrien E. Ibrahim et al.
CIRCULATION RESEARCH (2018)
New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging
Claudio de Lucia et al.
FRONTIERS IN PHARMACOLOGY (2018)
Regional interaction between myocardial sympathetic denervation, contractile dysfunction, and fibrosis in heart failure with preserved ejection fraction: 11C- hydroxyephedrine PET study
Tadao Aikawa et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
miRNAs as biomarkers for diagnosis of heart failure A systematic review and meta-analysis
Hualin Yan et al.
MEDICINE (2017)
Epidemiology, Pathophysiology, and Prognosis of Heart Failure in Older Adults
Kumar Dharmarajan et al.
HEART FAILURE CLINICS (2017)
Association of Holter-Derived Heart Rate Variability Parameters With the Development of Congestive Heart Failure in the Cardiovascular Health Study
Vaiibhav N. Patel et al.
JACC-HEART FAILURE (2017)
An Overview of Heart Rate variability Metrics and Norms
Fred Shaffer et al.
FRONTIERS IN PUBLIC HEALTH (2017)
microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases
Claudio de Lucia et al.
FRONTIERS IN MEDICINE (2017)
Adrenergic Receptors in Individual Ventricular Myocytes The Beta-1 and Alpha-1B Are in All Cells, the Alpha-1A Is in a Subpopulation, and the Beta-2 and Beta-3 Are Mostly Absent
Bat-Erdene Myagmar et al.
CIRCULATION RESEARCH (2017)
The differences in the relationship between diastolic dysfunction, selected biomarkers and collagen turn-over in heart failure patients with preserved and reduced ejection fraction
Blazej Michalski et al.
CARDIOLOGY JOURNAL (2017)
Prognostic Value of Lymphocyte G Protein-Coupled Receptor Kinase-2 Protein Levels in Patients With Heart Failure
Giuseppe Rengo et al.
CIRCULATION RESEARCH (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials
Ewa A. Jankowska et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Adrenergic signaling in heart failure and cardiovascular aging
Gaetano Santulli et al.
MATURITAS (2016)
Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study
G. Michael Felker et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
123I-MIBG Imaging for Prediction of Mortality and Potentially Fatal Events in Heart Failure: The ADMIRE-HFX Study
Jagat Narula et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
The Autonomic Nervous System and Heart Failure
Viorel G. Florea et al.
CIRCULATION RESEARCH (2014)
G Protein-Coupled Receptor Kinase 2 A Link Between Myocardial Contractile Function and Cardiac Metabolism
Meryl C. Woodall et al.
CIRCULATION RESEARCH (2014)
Natriuretic Peptides in Heart Failure
Danny C. C. Lin et al.
CLINICAL CHEMISTRY (2014)
β- Adrenergic blockade combined with subcutaneous B-type natriuretic peptide: a promising approach to reduce ventricular arrhythmia in heart failure?
Jerome Thireau et al.
HEART (2014)
Autonomic Dysfunction in Alzheimer's Disease: Tools for Assessment and Review of the Literature
Grazia Daniela Femminella et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Reduction of lymphocyte G protein-coupled receptor kinase-2 (GRK2) after exercise training predicts survival in patients with heart failure
Giuseppe Rengo et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2014)
Biomarkers and diagnostics in heart failure
Hanna K. Gaggin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Adrenergic Nervous System in Heart Failure Pathophysiology and Therapy
Anastasios Lymperopoulos et al.
CIRCULATION RESEARCH (2013)
Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure
Dirk J. Lok et al.
CLINICAL RESEARCH IN CARDIOLOGY (2013)
The potential role of valsartan+AHU377 (LCZ696) in the treatment of heart failure
Adriaan A. Voors et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Soluble ST2 Serum Concentration and Renal Function in Heart Failure
Antoni Bayes-Genis et al.
JOURNAL OF CARDIAC FAILURE (2013)
A Pooled Analysis of Multicenter Cohort Studies of 123I-mIBG Imaging of Sympathetic Innervation for Assessment of Long-Term Prognosis in Heart Failure
Tomoaki Nakata et al.
JACC-CARDIOVASCULAR IMAGING (2013)
Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea
Ravi V. Shah et al.
EUROPEAN HEART JOURNAL (2012)
The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: Implications for neural control of cardiac excitability
Neil Herring et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Acute Changes in N-Terminal Pro-B-Type Natriuretic Peptide During Hospitalization and Risk of Readmission and Mortality in Patients With Heart Failure
Henry J. Michtalik et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
G Protein-Coupled Receptor Kinase 2 in Patients With Acute Myocardial Infarction
Gaetano Santulli et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
Rudolf A. de Boer et al.
ANNALS OF MEDICINE (2011)
Natriuretic Peptide Testing in Heart Failure
Han-Na Kim et al.
CIRCULATION (2011)
Impairment of autonomic reactivity is a feature of heart failure whether or not the left ventricular ejection fraction is normal
Hitesh Patel et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Galectin-3: A Novel Blood Test for the Evaluation and Management of Patients With Heart Failure
Peter A. McCullough et al.
REVIEWS IN CARDIOVASCULAR MEDICINE (2011)
Dynamic Changes in Lymphocyte GRK2 Levels in Cardiac Transplant Patients: A Biomarker for Left Ventricular Function
Raphael E. Bonita et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2010)
Iron deficiency: an ominous sign in patients with systolic chronic heart failure
Ewa A. Jankowska et al.
EUROPEAN HEART JOURNAL (2010)
Myocardial Iodine-123 Meta-Iodobenzylguanidine Imaging and Cardiac Events in Heart Failure Results of the Prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) Study
Arnold F. Jacobson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Mid-Region Pro-Hormone Markers for Diagnosis and Prognosis in Acute Dyspnea Results From the BACH (Biomarkers in Acute Heart Failure) Trial
Alan Maisel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Catestatin: A multifunctional peptide from chromogranin A
Sushil K. Mahata et al.
REGULATORY PEPTIDES (2010)
The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance
Ersilia Cipolletta et al.
CARDIOVASCULAR RESEARCH (2009)
Increased muscle sympathetic nerve activity predicts mortality in heart failure patients
Antonio C. P. Barretto et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Myocardial and Peripheral Lymphocytic Transcriptomic Dissociation of β-adrenoceptors and G Protein-coupled Receptor Kinases in Heart Transplantation
Jaime Agueero et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2009)
The Sympathetic Nervous System in Heart Failure Physiology, Pathophysiology, and Clinical Implications
Filippos Triposkiadis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Heart Rate in Coronary Syndromes and Heart Failure
Francesco Orso et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2009)
Cardiac resynchronization therapy modifies the neurohormonal profile, hemodynamic and functional capacity in heart failure patients
Endrj Menardi et al.
ARCHIVES OF MEDICAL RESEARCH (2008)
Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure
Thomas Mueller et al.
CLINICAL CHEMISTRY (2008)
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
Kim Fox et al.
LANCET (2008)
Cardiac troponin and outcome in acute heart failure
W. Frank Peacock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Adrenal adrenoceptors in heart failure: fine-tuning cardiac stimulation
Anastasios Lymperopoulos et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure
Roberto Latini et al.
CIRCULATION (2007)
Measurement of the interleukin family member ST2 in patients with acute dyspnea
James L. Januzzi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
IL-33 and ST2 comprise a critical biomechanically induced and card ioprotective signaling system
Shoji Sanada et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure
Gregg C. Fonarow et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker
Colin Berry et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea
Antoni Bayes-Genis et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Lymphocyte levels of GRK2 (βARK1) mirror changes in the LVAD-supported failing human heart:: Lower GRK2 associated with improved β-adrenergic signaling after mechanical unloading
Jonathan A. Hata et al.
JOURNAL OF CARDIAC FAILURE (2006)
Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure
G Iaccarino et al.
EUROPEAN HEART JOURNAL (2005)
Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure
M Petersson et al.
EUROPEAN HEART JOURNAL (2005)
Transduction of receptor signals by β-arrestins
RJ Leftowitz et al.
SCIENCE (2005)
How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review
JA Doust et al.
BRITISH MEDICAL JOURNAL (2005)
Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction
UC Sharma et al.
CIRCULATION (2004)
Galanin and neuropeptide Y reduce cholinergic transmission in the heart of the anaesthetised mouse
MA Smith-White et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
IS Anand et al.
CIRCULATION (2003)
B-type natriuretic peptide as a marker of the effects of enalapril in patients with heart failure
M Yoshimura et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Chromogranin A in heart failure - A novel neurohumoral factor and a predictor for mortality
C Ceconi et al.
EUROPEAN HEART JOURNAL (2002)
Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction
B Stanek et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Heart rate variability measurement correlates with cardiac norepinephrine spillover in congestive heart failure
H Tygesen et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Upregulation of β2-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium
S Moniotte et al.
CIRCULATION (2001)
Share Paper
